Chlorhexidine Vaginal Cleansing Versus Iodine Prior to C-section and the Rate of Postoperative Infection

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT03431701
• Date of registration: 05/02/2018
• Prospective Registration: Yes
• Primary sponsor: Makassed General Hospital
• Public title: Chlorhexidine Vaginal Cleansing Versus Iodine Prior to C-section and the Rate of Postoperative Infection
• Scientific title: Chlorhexidine Vaginal Cleansing Versus Iodine Prior to C-section and the Rate of Postoperative Infection: Randomized Clinical Trial
• Date of first enrolment: February 8, 2018
• Target sample size: 333
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT03431701
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Single (Participant).
• Phase: N/A

Countries of recruitment

Lebanon

Contacts

• Name: Manal Hubesih, MD
• Affiliation: Makassed General Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- all pregnant women who will undergo cesarean delivery

- and willing to sign the informed consent.

Exclusion Criteria:

- Known allergy to the antiseptics used

- Infection diagnosis on admission

- Age = 17 years



Age minimum: 18 Years
Age maximum: N/A
Gender: Female

Health Condition(s) or Problem(s) studied

Vaginal Scrubbing

Intervention(s)

Other: Antibiotics

Other: Chlorhexidine

Other: Iodine

Primary Outcome(s)

Infectious morbidities [Time Frame: Within 30 days]

Secondary Outcome(s)

Readmission to the hospital [Time Frame: Within 30 days]

Length of hospital stay [Time Frame: Within 30 days]

Secondary ID(s)

01022018

Source(s) of Monetary Support

Please refer to primary and secondary sponsors